Literature DB >> 18721523

Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography.

Stefano Caselli1, Antonio Pelliccia, Martin Maron, Daria Santini, Danilo Puccio, Andrea Marcantonio, Natesa G Pandian, Stefano De Castro.   

Abstract

In clinical practice, differential diagnosis among different forms of left ventricular (LV) hypertrophy is not always easy, and hypertrophic cardiomyopathy (HC) can be misdiagnosed. In this study, it was hypothesized that a 3-dimensional echocardiographically derived index of LV regional mass distribution could be useful in differentiating HC from other forms of LV hypertrophy. Sixty-eight subjects underwent 2- and 3-dimensional echocardiography; of these, 20 were healthy volunteers, 18 were top-level athletes, 15 had essential hypertension, and 15 had HC. In off-line analysis, a 12-segment model was generated for segmental mass measurement. A mass dispersion index (MDI) was calculated as the average of the SDs of segmental mass values at the basal, middle, and apical layers. The ratio of ventricular septal thickness to posterior wall thickness was also calculated using 2-dimensional echocardiography. Patients with HC had significantly higher MDI values (1.75 +/- 0.43) than healthy volunteers (0.39 +/- 0.13) (p <0.0001), athletes (0.49 +/- 0.12) (p <0.0001), and patients with hypertension (0.38 +/- 0.10) (p <0.0001). The ratio of ventricular septal thickness to posterior wall thickness was significantly higher in patients with HC (1.31 +/- 0.23) than normal subjects (1.04 +/- 0.05) (p <0.0001), highly trained athletes (1.03 +/- 0.06) (p = 0.001), and patients with hypertension (1.06 +/- 0.06) (p = 0.002). However, receiver-operating characteristic analysis showed a higher sensitivity for MDI (93.3% for the cut-off value of 1.13) than the ratio of ventricular septal thickness to posterior wall thickness (66.7% for the cut-off value of 1.20), with excellent specificity for both (100%) in identifying patients with HC. In conclusion, the 3-dimensional echocardiographically derived MDI could be considered a useful and reliable additional tool in differentiating HC from other forms of LV hypertrophy.

Entities:  

Mesh:

Year:  2008        PMID: 18721523     DOI: 10.1016/j.amjcard.2008.04.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.

Authors:  Jeong Rang Park; Jin-Oh Choi; Hye Jin Han; Sung-A Chang; Sung-Ji Park; Sang-Chol Lee; Yeon Hyeon Choe; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2011-04-24       Impact factor: 2.357

2.  Evolution of ventricular hypertrophy and myocardial mechanics in physiological and pathological hypertrophy.

Authors:  Fatih Yalçin; Nagehan Kucukler; Oscar Cingolani; Blaid Mbiyangandu; Lars Sorensen; Aurelio Pinherio; M Roselle Abraham; Theodore P Abraham
Journal:  J Appl Physiol (1985)       Date:  2018-01-04

Review 3.  Ultrasound in sports medicine: relevance of emerging techniques to clinical care of athletes.

Authors:  Eugene Sun Yim; Gianmichael Corrado
Journal:  Sports Med       Date:  2012-08-01       Impact factor: 11.928

4.  Could early septal involvement in the remodeling process be related to the advance hypertensive heart disease?

Authors:  Fatih Yalçin; Caner Topaloglu; Nagehan Kuçukler; Mehmet Ofgeli; Theodore P Abraham
Journal:  Int J Cardiol Heart Vasc       Date:  2015-04-08

Review 5.  The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy.

Authors:  Leonard Mandeş; Monica Roşca; Daniela Ciupercă; Bogdan A Popescu
Journal:  J Echocardiogr       Date:  2020-04-16

Review 6.  Basal Septal Hypertrophy as the Early Imaging Biomarker for Adaptive Phase of Remodeling Prior to Heart Failure.

Authors:  Fatih Yalçin; Hulya Yalçin; Nagehan Küçükler; Serbay Arslan; Oguz Akkuş; Alparslan Kurtul; Maria Roselle Abraham
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

7.  Two-dimensional strain profiles in patients with physiological and pathological hypertrophy and preserved left ventricular systolic function: a comparative analyses.

Authors:  Luis Afonso; Ashok Kondur; Mengistu Simegn; Ashutosh Niraj; Pawan Hari; Ramanjit Kaur; Preeti Ramappa; Jyotiranjan Pradhan; Deepti Bhandare; Kim A Williams; Sandip Zalawadiya; Aurelio Pinheiro; Theodore P Abraham
Journal:  BMJ Open       Date:  2012-08-17       Impact factor: 2.692

Review 8.  Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy.

Authors:  Vito Maurizio Parato; Valeria Antoncecchi; Fabiola Sozzi; Stefania Marazia; Annapaola Zito; Maria Maiello; Pasquale Palmiero
Journal:  Cardiovasc Ultrasound       Date:  2016-08-12       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.